FDA Inspection 1327450 — Nippon Sanso Matheson, Inc.

Nippon Sanso Matheson, Inc. — FEI 2916223

The FDA completed an inspection of Nippon Sanso Matheson, Inc. on Jul 8, 2026 in Kapolei, HI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 8, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kapolei, HI (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.